Cécile Cluzel

Director/Board Member at OSE IMMUNOTHERAPEUTICS

Finance

Consumer Services

Health Technology

Profile

Cécile Nguyen-Cluzel is currently an Independent Director at OSE Immunotherapeutics SA since 2024, a Partner at Latour Capital Management SAS starting in 2025, and a Senior Advisor at Apposite Capital LLP since 2024.
Formerly, Ms. Nguyen-Cluzel was a Partner at MBO+ SAS from 2008 to 2023.
Education includes a graduate degree from Université Paris Dauphine-PSL conferred in 1994.

Cécile Cluzel active positions

Companies	Position	Start
OSE IMMUNOTHERAPEUTICS	Director/Board Member	19/06/2024
Apposite Capital LLP Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-ins and growth capital requirements. It also acquires minority interest.	Private Equity Investor	01/01/2024
Latour Capital Management SAS Latour Capital Management SAS Investment ManagersFinance Latour Capital is an active manager which provides both equity and debt financing in small and medium-sized companies located in France. The firm targets companies operating in the business services sector with an enterprise value between EUR 50 million and EUR 300 million. It invests through buyout transactions, and looks to take both minority and majority stake positions in its investments.	Private Equity Investor	01/09/2025

All active positions of Cécile Cluzel

Former positions of Cécile Cluzel

Companies	Position	End
MBO+ SAS MBO+ SAS Investment ManagersFinance MBO+ SAS invests in lower mid-cap companies located in France with an enterprise value of EUR 20 - 200 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for LBO, shareholder liquidity, acquisitions and buyout capital transactions with an investment size of EUR 10 - 45 million.	Private Equity Investor	30/06/2023

See the detail of Cécile Cluzel's experience

Training of Cécile Cluzel

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Cécile Cluzel's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	5
MBO+ SAS MBO+ SAS Investment ManagersFinance MBO+ SAS invests in lower mid-cap companies located in France with an enterprise value of EUR 20 - 200 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing in the form of equity and quasi-equity for LBO, shareholder liquidity, acquisitions and buyout capital transactions with an investment size of EUR 10 - 45 million.	Finance
Université Paris Dauphine-PSL Université Paris Dauphine-PSL Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Apposite Capital LLP Apposite Capital LLP Investment ManagersFinance Apposite Capital invests in companies located in the United Kingdom and European with revenues of up to EUR 100 million. The firm focuses on the technology sector. It provides financing for MBOs, buy-ins and growth capital requirements. It also acquires minority interest.	Finance
Latour Capital Management SAS Latour Capital Management SAS Investment ManagersFinance Latour Capital is an active manager which provides both equity and debt financing in small and medium-sized companies located in France. The firm targets companies operating in the business services sector with an enterprise value between EUR 50 million and EUR 300 million. It invests through buyout transactions, and looks to take both minority and majority stake positions in its investments.	Finance
OSE Immunotherapeutics SA OSE Immunotherapeutics SA Pharmaceuticals: MajorHealth Technology Develops immunotherapy products for late-stage cancers	Health Technology